Health and Healthcare
10X Genomics Enters the Market With a Bang
Published:
Last Updated:
10X Genomics Inc. (NASDAQ: TXG) shares entered the market with a bang on Thursday. Its initial public offering went off at $54, well above the anticipated price of $39. The company originally expected to price its 10.0 million shares in the range of $36 to $38, with an overallotment option for an additional 1.5 million shares. The entire offering is valued up to $448.5 million.
The underwriters for the offering are Cowen, Goldman Sachs, JPMorgan and Merrill Lynch.
This life science technology company builds products to interrogate, understand and master biology. Its integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. The firm has built deep expertise across diverse disciplines including chemistry, biology, hardware and software.
The firm’s products have enabled researchers to make fundamental discoveries across multiple areas of biology, including oncology, immunology and neuroscience, and have helped empower the single-cell revolution hailed by Science magazine as the 2018 “Breakthrough of the Year.”
In the filing, 10x Genomics detailed its finances as follows:
Our revenue was $71.1 million and $146.3 million for 2017 and 2018, respectively, representing an annual growth rate of 106%, and $59.2 million and $109.4 million for the six months ended June 30, 2018 and 2019, respectively, representing an annual growth rate of 85%. We generated net losses of $18.8 million and $112.5 million for 2017 and 2018. Our 2018 net loss resulted substantially from charges of $62.4 million associated with intellectual property acquisitions for research and development in addition to the litigation contingency.
The company intends to use the net proceeds from this offering for general corporate purposes, including working capital, operating expenses and capital expenditures.
Shares of 10X Genomics were last seen up about 42% at $55.22, in a range of $52.00 to $58.00 on the day thus far. Just over 4 million shares have moved as of 11:45 a.m. Eastern.
24/7 Wall St.Cash Back Credit Cards Have Never Been This Good
Credit card companies are at war, handing out free rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.